Some trial individuals knowledgeable a slight increase in resting heart fee, which has also been noticed with other GLP-one receptor agonists. Nonetheless, its special action on glucagon receptors necessitates more study to evaluate lengthy-phrase metabolic outcomes.Tirzepatide isn’t for everyone. Your clinician will let you come to a decision no